Skip to main content

Volume 3 Supplement 2

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

  • Poster presentation
  • Open access
  • Published:

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors

Background

There is debate regarding whether surgical resection and/or lymphadenectomy are indicated for small nonfunctional pancreatic neuroendocrine tumors (PNETs). Myeloid cell population expansion in peripheral blood has been correlated with clinical stage of patients with solid tumors. We aim to determine if blood sampling can be used as a predictor of malignant potential in nonfunctional PNETs.

Methods

We prospectively measured cell counts in 29 patients with PNET using flow cytometry of fresh whole blood before and after surgery, including CD3+, CD8+, and CD4+ T cells; monocytes; and granulocytes. Correlations were sought with known clinical markers of malignant potential such as tumor size, grade, number of positive lymph nodes, and TNM stage using t-test and one-way ANOVA analysis (STATA Inc).

Results

In this small cohort of patients, there were no differences in circulating immune cell counts between patients with lymph node metastases versus those without, nor in patients with tumors > 2cm, nor in those patients with high grade tumors. Interestingly, patients with lymph node metastases had a significant decrease in number of circulating CD8+ T cells post operatively when compared to those with negative lymph nodes (p = 0.013). There was a similar decrease in monocyte count post operatively in patients with positive versus negative lymph nodes that did not reach significance (p = 0.056).

Conclusions

Our data do not provide evidence that circulating immune cell populations can be used as biomarkers of lymph node positivity or of malignant potential in PNET prior to resection.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jutric, Z., Grendar, J., Cottam, B. et al. Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors. j. immunotherapy cancer 3 (Suppl 2), P140 (2015). https://doi.org/10.1186/2051-1426-3-S2-P140

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2051-1426-3-S2-P140

Keywords